Argent Trust »

Biomarin Pharma Inc convertible/ shares owned by Argent Trust

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Argent Trust from 13F filings

Historical chart of Argent Trust investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Argent Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Argent Trust

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 25k 0.99
2023-09-30 $24k 25k 0.97
2023-06-30 $25k 25k 0.98

More positions owned by Argent Trust

Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Jpmorgan Chase & Co Common Stock (JPM)
SPDR S&P 500 Etf-equity (SPY)
Alphabet Common Stock (GOOGL)
Home Depot Common Stock (HD)
Ishares Etf-equity (IVV)
Abbvie Common Stock (ABBV)
Amazon Common Stock (AMZN)
Johnson & Johnson Common Stock (JNJ)
Chevron Corp Common Stock (CVX)
Walmart Common Stock (WMT)
Visa Common Stock (V)
Alphabet Common Stock (GOOG)
Coca-cola Common Stock (KO)

View all positions for Argent Trust

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/